Non-HDL cholesterol
All the cholesterol carried by artery-damaging particles, in one number — simply total cholesterol minus HDL. It captures more of the risk than LDL alone, needs no fasting, and stays reliable when triglycerides are high.
What it measures
Non-HDL cholesterol is exactly what its name says: total cholesterol minus the 'good' HDL cholesterol. What's left is the cholesterol inside every atherogenic (artery-damaging) particle — LDL, VLDL, IDL and remnants — not just LDL. That makes it a fuller measure of cardiovascular risk than LDL cholesterol on its own, and it has two practical advantages: it is calculated directly from a standard lipid panel with no extra test, and it does not need a fasting sample or a special formula, so it stays accurate even when triglycerides are high (the situation where calculated LDL becomes unreliable). Many guidelines now use non-HDL as a co-target alongside, or instead of, LDL — its target is simply set about 30 mg/dL above the LDL goal.
What a high value can mean
- Increased atherogenic cholesterol burden — the core meaning; higher non-HDL = higher cardiovascular risk.
- High triglycerides / metabolic syndrome / diabetes — where non-HDL is especially useful, capturing remnant-cholesterol risk that LDL misses.
- Familial hypercholesterolaemia — genetically high.
- Diet, hypothyroidism, kidney or liver disease.
- A high non-HDL with an 'acceptable' LDL — a clue that risk is underestimated by LDL alone.
What a low value can mean
- Low cardiovascular risk — favourable.
- Effective lipid-lowering treatment — a therapy goal.
- Very low values — occasionally hyperthyroidism, malnutrition or a genetic cause.
When to discuss with a doctor
Non-HDL is most useful when triglycerides are raised or you have diabetes or metabolic syndrome, because it captures risk that LDL alone underestimates and doesn't need fasting. A high non-HDL is a reason to address diet, weight and activity and, with your doctor, to consider or intensify lipid-lowering treatment toward a non-HDL target (roughly 30 mg/dL above your LDL goal, set by your overall risk). It is also a clean way to confirm treatment is working. Mediora.AI calculates non-HDL from your lipid panel and shows it beside LDL, ApoB and triglycerides so discordance is visible; the treatment decision and risk scoring belong with your GP or cardiologist.